CTH and hepatocellular carcinoma: Similarly, DNA hypermethylation of the CTH promoter caused by the FOXC1-mediated upregulation of DNA methylase 3B results in low CTH expression in HCC cells, and HCC patients with positive FOXC1 expression and negative CTH expression exhibit the worst prognosis (47).